Gene · 6652
Papers2,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diabetic complications and prospective immunotherapy. | Front Immunol | 2023 | 37483613 | PubTator, text mining | PubMed |
| Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. | J Enzyme Inhib Med Chem | 2023 | 37470409 | PubTator, text mining | PubMed |
| Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease. | Neuromuscul Disord | 2023 | 37455204 | PubTator, text mining | PubMed |
| Deep structured learning for variant prioritization in Mendelian diseases. | Nat Commun | 2023 | 37443090 | PubTator, text mining | PubMed |
| Traditional complementary and alternative medicine (TCAM) for diabetic foot ulcer management: A systematic review. | J Ayurveda Integr Med | 2023 | 37441954 | PubTator, text mining | PubMed |
| Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance. | Adv Sci (Weinh) | 2023 | 37436087 | PubTator, text mining | PubMed |
| Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer. | Breast Cancer (Dove Med Press) | 2023 | 37434588 | PubTator, text mining | PubMed |
| Pharmacological Cardioprotection against Ischemia Reperfusion Injury-The Search for a Clinical Effective Therapy. | Cells | 2023 | 37408266 | PubTator, text mining | PubMed |
| Clinical Features of a Newly Described Mutation of Myelin Protein Zero in a Family. | Cureus | 2023 | 37404437 | PubTator, text mining | PubMed |
| Evaluation of Pathogenicity and Causativity of Variants in the MPZ and SH3TC2 Genes in a Family Case of Hereditary Peripheral Neuropathy. | Int J Mol Sci | 2023 | 37372933 | PubTator, text mining | PubMed |
| Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate. | Biomedicines | 2023 | 37371657 | PubTator, text mining | PubMed |
| Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections. | Int J Mol Sci | 2023 | 37298303 | PubTator, text mining | PubMed |
| AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration. | Front Mol Neurosci | 2023 | 37266370 | PubTator, text mining | PubMed |
| Tracer metabolomics reveals the role of aldose reductase in glycosylation. | Cell Rep Med | 2023 | 37257447 | PubTator, text mining | PubMed |
| Chemical Composition of the Cinnamomum malabatrum Leaf Essential Oil and Analysis of Its Antioxidant, Enzyme Inhibitory and Antibacterial Activities. | Antibiotics (Basel) | 2023 | 37237843 | PubTator, text mining | PubMed |
| Gene and protein expression and metabolic flux analysis reveals metabolic scaling in liver ex vivo and in vivo. | Elife | 2023 | 37219930 | PubTator, text mining | PubMed |
| Whole-genome sequencing in clinically diagnosed Charcot-Marie-Tooth disease undiagnosed by whole-exome sequencing. | Brain Commun | 2023 | 37180992 | PubTator, text mining | PubMed |
| Role of cuproptosis in understanding diseases. | Hum Cell | 2023 | 37154876 | PubTator, text mining | PubMed |
| The connection of α- and β-domains in mammalian metallothionein-2 differentiates Zn(II) binding affinities, affects folding, and determines zinc buffering properties. | Metallomics | 2023 | 37147085 | PubTator, text mining | PubMed |
| From methodological limitations to the function of metallothioneins - a guide to approaches for determining weak, moderate, and tight affinity zinc sites. | Metallomics | 2023 | 37113075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6652/papers?page=7